The estimated Net Worth of Samraat S. Raha is at least $8.41 Milhão dollars as of 31 March 2021. Mr Raha owns over 1,000 units of Agilent Technologies stock worth over $7,480,923 and over the last 7 years he sold A stock worth over $127,500. In addition, he makes $797,778 as Sr. VP and Pres of Diagnostics & Genomics Group at Agilent Technologies.
Mr has made over 1 trades of the Agilent Technologies stock since 2021, according to the Form 4 filled with the SEC. Most recently he sold 1,000 units of A stock worth $127,500 on 31 March 2021.
The largest trade he's ever made was selling 1,000 units of Agilent Technologies stock on 31 March 2021 worth over $127,500. On average, Mr trades about 36 units every 0 days since 2018. As of 31 March 2021 he still owns at least 53,936 units of Agilent Technologies stock.
You can see the complete history of Mr Raha stock trades at the bottom of the page.
Samraat S. Raha is the Sr. VP and Pres of Diagnostics & Genomics Group at Agilent Technologies.
As the Sr. VP and Pres of Diagnostics & Genomics Group of Agilent Technologies, the total compensation of Mr Raha at Agilent Technologies is $797,778. There are 8 executives at Agilent Technologies getting paid more, with Michael McMullen having the highest compensation of $12,520,600.
Mr Raha is 48, he's been the Sr. VP and Pres of Diagnostics & Genomics Group of Agilent Technologies since . There are 20 older and 5 younger executives at Agilent Technologies. The oldest executive at Agilent Technologies Inc. is Tadataka Yamada, 75, who is the Independent Director.
Samraat's mailing address filed with the SEC is 322 NORTH 2200 WEST, , SALT LAKE CITY, UT, 84116.
Over the last 22 years, insiders at Agilent Technologies have traded over $170,735,833 worth of Agilent Technologies stock and bought 25,786 units worth $823,096 . The most active insiders traders include William P Sullivan, George A Scangos, eMikael Dolsten. On average, Agilent Technologies executives and independent directors trade stock every 20 days with the average trade being worth of $3,748,368. The most recent stock trade was executed by Padraig Mcdonnell on 22 August 2024, trading 1,958 units of A stock currently worth $283,910.
analytical scientists and clinical researchers worldwide rely on agilent to help fulfill their most complex laboratory demands. our instruments, software, services and consumables address the full range of scientific and laboratory management needs—so our customers can do what they do best: improve the world around us. whether a laboratory is engaged in environmental testing, academic research, medical diagnostics, pharmaceuticals, petrochemicals or food testing, agilent provides laboratory solutions to meet their full spectrum of needs. we work closely with customers to help address global trends that impact human health and the environment, and to anticipate future scientific needs. our solutions improve the efficiency of the entire laboratory, from sample prep to data interpretation and management. customers trust agilent for solutions that enable insights...for a better world.
Agilent Technologies executives and other stock owners filed with the SEC include: